DOH launches website on COVID-19 drug supply | Inquirer News

DOH launches website on COVID-19 drug supply

/ 05:06 AM August 07, 2022

DOH logo with background showing coronavirus. STORY: DOH launches website on COVID-19 drug supply

INQUIRER.net FILE PHOTO

MANILA, Philippines — The Department of Health (DOH) recently launched a website where patients can check the availability of COVID-19 drugs with regulatory approval for emergency use in health facilities in their area.

The link, COVID-19 Meds Tracker, contains a list of the health facilities per region with supply of COVID-19 medicines. It has a filter feature where the user can easily find the drug they need from a specific hospital in a certain region or province.

Article continues after this advertisement

If the antiviral pill, vial or intravenous fluid (IV) has more than 100 stocks in a certain facility, it would be labeled as “available,” while those with a supply with only 50 to 100 would be tagged as “limited.”

FEATURED STORIES

If it is below 50, it is already marked “not available.” Among the COVID-19 medicines approved for emergency use are molnupiravir, baricitinib, both generic names of antiviral pills; and remdesivir, casirivmab, and tocilizumab, all of which are IV solutions.

—KATHLEEN DE VILLA

RELATED STORY

Article continues after this advertisement

DOH eyes access of COVID-19 drugs through retailers

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.